ABSTRACT -Emetic responses to cisplatin and participation of vagal innervation in emesis were studied in suncus. Intraperitoneal and intravenous administration of cis platin caused dose-dependent emesis. ED50 values, latencies and frequencies were not significantly different between the two administrations. Cis-diagodiammineplatinum (DAP), an active metabolite of cisplatin, also induced emesis, but with significantly shorter latency. Vagotomy completely abolished both types of vomiting. These results suggest that cisplatin is metabolized to DAP that subsequently causes emesis through stimulation of the vagus afferent.
Cisplatin is an effective anticancer chemo therapeutic agent that acts against a variety of tumors such as tumors of the testicles, head and neck, and bladder (1, 2), whereas it is considered as one of the most emetogenic anticancer drugs (3) . Nausea and vomiting during the treatment of cisplatin made a num ber of patients refuse further treatment be cause of serious discomfort (4) . A great num ber of clinical and experimental studies on cisplatin-induced emesis have been reported using carnivores such as dogs, cats and ferrets (5) (6) (7) (8) (9) . However, the exact mechanism that causes emesis is still unknown. Recently we have reported that Suncus murinus, a species of the insectivore, vomits in response to vari ous emetic drugs (10), motion sickness or cancer chemotherapeutics including cisplatin (11) . The cisplatin-induced emesis in suncus was effectively blocked by serotonergic 5-HT3 receptor antagonists (12) . However, cisplatin induced emesis in the suncus has not been characterized yet.
Healthy male adult suncus weighing 50 80 g were purchased from the Central Institute for Experimental Animals (Kawasaki, Japan). All animals were bred under a 12 hr light/dark cycle with free access to food and water. Experimental conditions and prepara tion of cisplatin solution were the same as those reported previously (10, 12) . Cis diaqodiammineplatinum(II) (DAP), a putative active metabolite of cisplatin (13) , was prepared from cis-diagodiammineplatinum(II) dinitrate neutralized by 1 N NaOH (14) . All solutions were prepared just before the injec tion to animals.
Intravenous administration into the jugular vein was performed under light ether anesthe sia. In several animals, an abdominal vago tomy was achieved under ether anesthesia. The ventral vagi attached to the esophagus just be low the diaphragm was isolated and sectioned. These animals were allowed to recover for several weeks before being tested. The time from the injection of drugs to the first vomit ing episode (latency) and the number of vomiting episodes for 120 min were recorded.
Emesis in suncus was produced by intra venous or intraperitoneal injection of cis platin. The administration of cisplatin at a dose of 5, 10 and 20 mg/kg showed a dose related increase in the emetic response ( Table 1) . None of the animals died during the 120-min observation period. The ED50 values, calculated using Brownlee's up-and-down method, were 8.4 mg/kg for intravenous injec tion and 10.0 mg/kg for intraperitoneal injec tion. The latency of the emetic response and number of vomiting episodes were not signifi cantly different between the two routes of administration. These results suggest either that cisplatin is easily absorbed from the abdominal cavity or that the drug stimulates the abdominal sensory system to induce eme sis regardless of the route of administration. Table 2 ). The number of vomiting episodes was not significantly differ ent from those induced by the same molar dose of cisplatin. The long latency is charac teristic of cisplatin-induced emesis which has been already reported in other species such as ferrets (9) . However, the latency of DAP induced emesis was significantly shorter than that of cisplatin (17.8 ± 2.4 min vs. 51.2 ± 3.4 min, P < 0.01 by Student's t-test). Duration of the DAP-induced vomiting, time between the first and the last episode, was also significantly shorter than that caused by cisplatin (20.2 ± 3.9 min vs. 57.6 ± 12.7 min, P < 0.05 by Stu dent's t-test). The vagotomy also completely abolished DAP-induced emesis (N = 4). Sodium nitrate that is a byproduct of DAP had no vomiting effect in suncus. These results suggest that the long latency of cisplatin-in duced emesis reflects the time necessary for the conversion to DAP. It is not known at the present whether DAP directly causes emesis or it must be converted further to another emetogenic substance. However, the shorter latency and duration but similar frequencies of DAP-induced emesis and prevention by the vagotomy readily indicate that cisplatin is metabolized to DAP which then causes vomit ing.
This is the first report that a putative metabolite of cisplatin has emetogenic effects. It would be clearer if we could show the con version of cisplatin into the metabolite in vivo. However, cisplatin and its metabolites are che mically very reactive, and our attempt to sepa rate these compounds in serum using a high performance liquid chromatography has not been successful.
Hawthorn et al. (15) reported that a com bination of bilateral vagotomy and greater splanchnic nerve section totally abolished cisplatin-induced retching and vomiting in fer rets. However, the effects of vagotomy on cisplatin-induced emesis in other species have not been reported. In the present study, we showed that surgical vagotomy without the splanchnic nerve section is enough to prevent the emesis in suncus. Since the combination of atropine and hexamethonium was not effec tive, the vagus afferent is very important for the emesis in suncus. Serotonergic 5-HT3 re ceptor antagonists strongly prevent cisplatin induced emesis in ferrets (9) and suncus (12) . Taken together, these results indicate that cis platin converts to a metabolite(s) which direct ly or indirectly stimulates 5-HT3 receptors lo cated on the vagus afferent and let signals transmit to the "vomiting center" presumably located in the medulla oblongata and then causes emesis.
